Healthpeak Properties (DOC) Expected to Announce Quarterly Earnings on Monday

Healthpeak Properties (NYSE:DOC) will likely be releasing its Q4 2025 results after the market closes on Monday, February 2nd. Analysts expect the company to announce earnings of $0.45 per share and revenue of $685.1350 million for the quarter. Individuals may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Tuesday, February 3, 2026 at 10:00 AM ET.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Thursday, October 23rd. The real estate investment trust reported $0.46 earnings per share for the quarter, topping the consensus estimate of $0.45 by $0.01. The company had revenue of $705.87 million for the quarter, compared to analysts’ expectations of $681.65 million. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.44%. Healthpeak Properties’s revenue for the quarter was up .8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.45 earnings per share. On average, analysts expect Healthpeak Properties to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Healthpeak Properties Trading Up 1.7%

Shares of Healthpeak Properties stock opened at $18.09 on Monday. Healthpeak Properties has a 1 year low of $15.71 and a 1 year high of $21.28. The firm has a market cap of $12.57 billion, a PE ratio of -361.65, a PEG ratio of 4.62 and a beta of 1.12. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.22 and a quick ratio of 1.22. The company has a 50 day simple moving average of $17.02 and a two-hundred day simple moving average of $17.68.

Healthpeak Properties Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a dividend of $0.1017 per share. The ex-dividend date is Tuesday, March 17th. This represents a c) annualized dividend and a dividend yield of 6.7%. Healthpeak Properties’s dividend payout ratio (DPR) is -2,440.00%.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Cantor Fitzgerald set a $17.00 target price on shares of Healthpeak Properties in a research report on Monday, January 5th. Wells Fargo & Company lifted their price target on Healthpeak Properties from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 25th. The Goldman Sachs Group began coverage on Healthpeak Properties in a report on Friday, January 9th. They issued a “neutral” rating and a $17.00 price objective for the company. Robert W. Baird reduced their price objective on Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 12th. Finally, Weiss Ratings cut Healthpeak Properties from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, January 12th. Six research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $19.67.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of DOC. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Healthpeak Properties by 694.6% in the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock worth $153,520,000 after buying an additional 7,007,777 shares during the period. Bank of America Corp DE grew its position in Healthpeak Properties by 28.5% during the 3rd quarter. Bank of America Corp DE now owns 9,936,934 shares of the real estate investment trust’s stock worth $190,292,000 after acquiring an additional 2,206,222 shares during the last quarter. State Street Corp grew its position in Healthpeak Properties by 1.8% during the 3rd quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock worth $947,889,000 after acquiring an additional 895,460 shares during the last quarter. Verition Fund Management LLC increased its stake in Healthpeak Properties by 242.2% in the 3rd quarter. Verition Fund Management LLC now owns 1,195,452 shares of the real estate investment trust’s stock worth $22,893,000 after purchasing an additional 846,066 shares during the period. Finally, UBS Group AG increased its stake in Healthpeak Properties by 33.6% in the 3rd quarter. UBS Group AG now owns 3,349,298 shares of the real estate investment trust’s stock worth $64,139,000 after purchasing an additional 841,614 shares during the period. Hedge funds and other institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.